Shionogi

National / Science & Health Feb 24, 2018

One-dose flu drug Xofluza gets nod from health ministry

by Tomoko Otake

Osaka-based drugmaker Shionogi & Co. has announced that the health ministry gave it approval to manufacture and market its new flu drug Xofluza, which requires only a single dose regardless of age. The drug, which has been approved in tablet form for use against the ...

Business / Corporate Sep 29, 2017

Opioids demand rises in Japan as seniors use drugs to ease pain and improve quality of life

by Kanoko Matsuyama

Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer. Now demand is taking off and drugmakers are introducing new products to a ...